Recombinant Human C1 Inhibitor (Conestat Alfa): In the Treatment of Angioedema Attacks in Hereditary Angioedema

ISSN： 1173-8804

Source： BioDrugs, Vol.26, Iss.5, 2012-10, pp. : 315-323

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recombinant C1-Inhibitor: Effects on Coagulation and Fibrinolysis in Patients with Hereditary Angioedema

By Relan Anurag

BioDrugs, Vol. 26, Iss. 1, 2012-02 ,pp. : 43-52

Adis International

Access to resources Recommend Favorite

Nanofiltered Human C1 Inhibitor Concentrate (Cinryze®): In Hereditary Angioedema

By Lyseng-Williamson Katherine A.

BioDrugs, Vol. 25, Iss. 5, 2011-10 ,pp. : 317-327

Adis International

Access to resources Recommend Favorite

Ecallantide in Acute Hereditary Angioedema†: Profile Report

By Garnock-Jones Karly P.

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 51-52

Adis International

Access to resources Recommend Favorite

Potentially lethal ACE‐inhibitor‐induced angioedema in a child

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 427-430

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute Urticaria and Angioedema: Diagnostic and Treatment Considerations

By Frigas Evangelo Park Miguel A.

American Journal of Clinical Dermatology, Vol. 10, Iss. 4, 2009-06 ,pp. : 239-250

Adis International

Access to resources Recommend Favorite